Yajing Liu

644 total citations
27 papers, 537 citations indexed

About

Yajing Liu is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Yajing Liu has authored 27 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yajing Liu's work include Liver physiology and pathology (9 papers), Cancer Mechanisms and Therapy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Yajing Liu is often cited by papers focused on Liver physiology and pathology (9 papers), Cancer Mechanisms and Therapy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Yajing Liu collaborates with scholars based in China, United States and United Kingdom. Yajing Liu's co-authors include Ping Gong, Lixiang Ren, Shang Li, Shoumin Bai, April Davis, Shawn G. Clouthier, Max S. Wicha, Ramdane Harouaka, Tahra Luther and Michael Brooks and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yajing Liu

25 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yajing Liu China 15 258 185 136 91 65 27 537
Young‐Choon Moon United States 10 451 1.7× 84 0.5× 235 1.7× 31 0.3× 26 0.4× 23 661
Jihye Ryu South Korea 17 312 1.2× 48 0.3× 149 1.1× 39 0.4× 20 0.3× 38 592
Christophe Henry France 12 160 0.6× 100 0.5× 158 1.2× 24 0.3× 17 0.3× 25 459
Xiaofang Zhao China 11 192 0.7× 66 0.4× 216 1.6× 55 0.6× 19 0.3× 27 551
Nagore I. Marín‐Ramos United States 13 207 0.8× 46 0.2× 114 0.8× 30 0.3× 19 0.3× 18 406
Timothy J. Eisen United States 7 367 1.4× 94 0.5× 216 1.6× 13 0.1× 29 0.4× 12 589
Yinghui Song China 15 378 1.5× 71 0.4× 133 1.0× 35 0.4× 43 0.7× 61 653
Yufei Xiang China 10 193 0.7× 117 0.6× 90 0.7× 63 0.7× 14 0.2× 24 630
Zhihao Liu China 15 438 1.7× 183 1.0× 131 1.0× 16 0.2× 36 0.6× 54 688
Edward J. Jarman United Kingdom 10 214 0.8× 45 0.2× 83 0.6× 38 0.4× 22 0.3× 13 425

Countries citing papers authored by Yajing Liu

Since Specialization
Citations

This map shows the geographic impact of Yajing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Liu more than expected).

Fields of papers citing papers by Yajing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Liu. The network helps show where Yajing Liu may publish in the future.

Co-authorship network of co-authors of Yajing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yajing Liu. A scholar is included among the top collaborators of Yajing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajing Liu. Yajing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Tingting, Shuman Wang, Yajing Liu, Xiaoming Bai, & Shilin Chen. (2025). Roles and mechanisms of cuproptosis for reversing cancer therapeutic resistance. International Journal of Pharmaceutics. 685. 126267–126267.
2.
3.
Yan, Xiaojun, et al.. (2024). Doxorubicin induces deglycosylation of cancer cell‐intrinsic PD‐1 by NGLY1. FEBS Letters. 598(12). 1543–1553. 1 indexed citations
4.
Sitto, Merna, Sundaresh Ram, Wenbin Ji, et al.. (2023). The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity. Journal of Biological Chemistry. 299(6). 104786–104786. 1 indexed citations
5.
Liu, Yajing, et al.. (2022). The use of three-dimensional endoscope in transnasal skull base surgery: A single-center experience from China. Frontiers in Surgery. 9. 996290–996290. 3 indexed citations
6.
Wang, JinRong, et al.. (2021). Relationship between end-tidal carbon dioxide and arterial carbon dioxide in critically ill patients on mechanical ventilation. Medicine. 100(33). e26973–e26973. 4 indexed citations
7.
Huang, Qiong, Shao-wei Li, Xingbin Hu, et al.. (2020). Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation. Journal of Experimental & Clinical Cancer Research. 39(1). 25–25. 44 indexed citations
8.
Zhang, Jing, et al.. (2020). Research on Safety Evaluation System of Optical Storage Charging Station Based on Fuzzy Theory. 2900–2903. 2 indexed citations
9.
Wang, Yang, et al.. (2020). Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 194. 112244–112244. 42 indexed citations
10.
Wang, Zhen, Wenwen Zhao, Yunlei Hou, et al.. (2020). Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors. Bioorganic Chemistry. 105. 104371–104371. 17 indexed citations
11.
Ding, Shi, et al.. (2020). Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 20(5). 559–570. 1 indexed citations
12.
Xu, Qiaoling, Hong Yue, Yong Luo, et al.. (2018). Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B. Bioorganic & Medicinal Chemistry. 26(9). 2621–2631. 19 indexed citations
13.
Yang, Xiuxiu, et al.. (2017). Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry. 25(16). 4475–4486. 30 indexed citations
14.
Liu, Yajing, Monika L. Burness, Rachel Martin-Trevino, et al.. (2016). RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer. Clinical Cancer Research. 23(2). 514–522. 123 indexed citations
15.
Zhang, Feng, et al.. (2016). Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 123. 431–446. 43 indexed citations
16.
Hu, Gang, Zhuang Guo, Deyu Sun, et al.. (2015). Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry. 23(15). 4410–4422. 28 indexed citations
17.
Xu, Chen, Xiaohui Ji, Gang Hu, et al.. (2014). Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 87. 508–518. 27 indexed citations
18.
Liu, Yajing, M. Virginia C. L. Appleyard, Philip J. Coates, & Alastair M. Thompson. (2009). p53 and γ radiation in the normal breast. International Journal of Radiation Biology. 85(11). 1026–1031. 1 indexed citations
19.
Wei, Jia, Yajing Liu, Wei Li, et al.. (2009). Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols. Bioorganic & Medicinal Chemistry. 17(13). 4569–4574. 22 indexed citations
20.
Liu, Yajing, et al.. (2008). Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro. Bioorganic & Medicinal Chemistry. 16(13). 6522–6527. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young‐Choon Moon Breakdown of academic impact, for papers by Jihye Ryu Breakdown of academic impact, for papers by Christophe Henry Breakdown of academic impact, for papers by Xiaofang Zhao Breakdown of academic impact, for papers by Nagore I. Marín‐Ramos Breakdown of academic impact, for papers by Timothy J. Eisen Breakdown of academic impact, for papers by Yinghui Song Breakdown of academic impact, for papers by Yufei Xiang Breakdown of academic impact, for papers by Zhihao Liu Breakdown of academic impact, for papers by Edward J. Jarman
Rankless by CCL
2026